Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Nastech Pharmaceutical (NasdaqNM:NSTK)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Msgs | Insider | Financials | Reports
Location
45 Adams Avenue
Hauppauge, NY 11788
Phone: (631) 273-0101
Fax: (631) 273-0252
Employees (last reported count): 52
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Related Links
 ·Search Yahoo! for related links...
Ownership
·Insider and 5%+ Owners: 43%
·Institutional: 17% (30% of float)
(21 institutions)
·Net Inst. Buying: 15.0K shares (+1.12%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Nastech Pharmaceutical Company Inc. is engaged in the research, development and manufacture of nasally administered prescription pharmaceuticals. Although the oral route of drug delivery may be the most popular and least expensive method of delivery, gastrointestinal and liver metabolism can reduce an oral drug's effectiveness. Generally, a nasal delivery system will provide faster absorption into the blood stream than an oral product, thereby resulting in faster onset of action. The Company has a commercial interest in two nasal drug products, both of which are approved for sale in the United States. Its licensee Bristol-Myers Squibb Company markets Stadol NSTM (Butorphanol Tartrate), and its licensee Schwarz Pharma Inc. markets Nascobal (Cyanocobalamin, USP). In addition to these two drugs, the Company has several drugs in various stages of drug research and development.
More from Market Guide: Expanded Business Description

Financial Summary
NSTK is engaged in the research, development, manufacturing and commercialization of nasally administered forms of pharmaceuticals that are currently delivered in oral, injectable or other dosage forms. For the six months ended 6/30/01, revenues fell 20% to $1.7 million. Net loss fell 1% to $4.4 million. Revenues reflect a decline in royalty income from BMS on sales of Stadol NS. Lower loss reflects lower R&D, royalty, market research and compensation expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Steven Quay, M.D., Ph.D., 50
Chairman, Pres, CEO
$136K
Andrew Zinzi, 54
CFO
199K
David Wormuth, 55
Sr. VP
--  
Joel Girsky, 61
Treasurer, Director
--  
Carol Wenig, 56
Sec.
118K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:NSTKAs of 31-Aug-2001
Price and Volume
52-Week Low
on 21-Mar-2001
$3.875
Recent Price$8.59 
52-Week High
on 10-July-2001
$11.37 
Beta1.10 
Daily Volume (3-month avg)52.7K
Daily Volume (10-day avg)35.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+37.4%
52-Week Change
relative to S&P500
+84.4%
Share-Related Items
Market Capitalization$67.8M
Shares Outstanding7.89M
Float4.50M
Dividends & Splits
Annual Dividendnone 
Last Split: 1 for 3 on 8-Nov-1993
Per-Share Data
Book Value (mrq)$1.29 
Earnings (ttm)-$1.40 
Earnings (mrq)-$0.27 
Sales (ttm)$0.62 
Cash (mrq)$0.96 
Valuation Ratios
Price/Book (mrq)6.67 
Price/EarningsN/A 
Price/Sales (ttm)13.77 
Income Statements
Sales (ttm)$4.38M
EBITDA (ttm)-$8.85M
Income available to common (ttm)-$9.64M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-74.05%
Return on Equity (ttm)-89.00%
Financial Strength
Current Ratio (mrq)4.61 
Debt/Equity (mrq)0 
Total Cash (mrq)$7.60M
Short Interest
As of 8-Aug-2001
Shares Short85.0K
Percent of Float1.9%
Shares Short
(Prior Month)
95.0K
Short Ratio2.02 
Daily Volume42.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.